Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 8 of 8 citing Aso: Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflam.... (0.09 sec) 

Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for …


F Karakurt, II Gumus, N Bavbek, A Kargili, C … - Gynecological Endocrinology, 2008 - informahealthcare.com
Objectives. Our study was undertaken to evaluate the levels of
thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and also its
relationship with other hemostasis markers in a group of patients affected ...
Cited by 4 - Related articles - All 4 versions

凝血酶激活的纤溶抑制物与糖尿病关系的研究进展


谢玮, 刘敏涓 - 广州医药, 2007 - 万方数据资源系统
凝血酶激活的纤溶抑制物(thrombin-activatable fibrinolysis inhibitor, TAFI)是近年被
证实的一种新的纤维蛋白溶解抑制剂.它的发现是对经典的凝血及纤维调控途径的重要补充 ...
Cited by 2 - Related articles - All 3 versions

Impact of the therapy by renin–angiotensin system targeting antihypertensive agents …


A Remková, H Kratochvíl'ová… - Journal of human hypertension, 2008 - nature.com
The aim of the study was to investigate the effect of therapy by perindopril or
telmisartan on endothelial/platelet function and on coagulation/fibrinolysis in
20 and 16 hypertensive patients, respectively. The measurements were ...
Cited by 1 - Related articles - BL Direct - All 4 versions

C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels …


R Testa, AR Bonfigli, C Sirolla, M Marra, M … - Nutrition, Metabolism and Cardiovascular Diseases, 2008 - Elsevier
Two hundred and ninety-five type 2 diabetic patients (age 60.9 ± 10.5 years)
and 290 healthy controls (age 59.2 ± 11.5 years) were enrolled. A significant
correlation between PAI-1 and CRP in diabetic subjects was found (r = 0.45, ...
Related articles - All 12 versions

[PDF] METABOLIC SYNDROME-A LITERATURE REVIEW


C Peters, 2007 - nursing.arizona.edu
Brief quotations from this thesis are allowable without special permission,
provided that accurate acknowledgement of source is made. Requests for
permission for extended quotation from or reproduction of this manuscript ...
Related articles - View as HTML - All 2 versions

Нарушения в системе гемостаза при сахарном диабете и пути их коррекции при …


АС Аметов, ОЛ Соловьева - Сахарный диабет, 2007 - elibrary.ru
Нарушения в системе гемостаза при сахарном диабете и пути их коррекции при назначении ...
Related articles

[PDF] Současné možnosti antiagregační léčby u nemocných s diabetem v prevenci komplikací …


J Špác - Kardiol Rev, 2006 - kardiologickarevue.cz
Funkční vlastnosti trombocytu jsou u diabe- tiků patologicky změněny.
Nemocní s diabetes mellitus mají krevní destičky s větším objemem než
nediabetici. Střední objem destiček je ukazatelem aktivace destiček, ...
Related articles - View as HTML

[PDF] Prevalencia del síndrome metabólico y su relación con nuevos marcadores de riesgo …


MB Cortés, PFJN Mogollón, 2009 - repositorio.ulpgc.es
Page 1. UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA DEPARTAMENTO DE CIENCIAS
MÉDICAS Y QUIRÚRGICAS TESIS DOCTORAL PREVALENCIA DEL ...
Related articles - View as HTML - All 4 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google